About
Addiction Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
166
By Phase
PHASE1: 1PHASE2: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06147622Lead Sponsor
A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine
PHASE1Completed
12 participants
Started: Apr 23, 2024 · Completed: Dec 31, 2024
NCT04108104Lead Sponsor
Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects
PHASE2Completed
154 participants
Started: Nov 30, 2019 · Completed: Jan 31, 2022
Locations (1)
Headquarters
Orléans, France
Map
Loading map...